BIO89-100
Phase 1- Indications
- Nonalcoholic steatohepatitis (NASH), Severe hypertriglyceridemia (SHTG)
Company intelligence / Profile preview
Cascade Cryobank operates as a commercial sperm bank with innovative practices such as comprehensive genetic screening and mental health evaluations for donors. Their Early Disclosure program allows consenting donors to connect with recipient families after a live birth—a first in the U.S.—promoting transparency and open relationships between donors and recipient families. The company has been FDA registered since 2022 and continues to expand its diverse donor catalog.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cascade Cryobank.